CICERI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 3.746
EU - Europa 3.618
AS - Asia 616
OC - Oceania 24
AF - Africa 22
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.042
Nazione #
US - Stati Uniti d'America 3.717
SE - Svezia 2.182
IT - Italia 855
CN - Cina 243
IE - Irlanda 124
FI - Finlandia 121
IN - India 95
DE - Germania 94
SG - Singapore 79
NL - Olanda 60
JP - Giappone 58
GB - Regno Unito 54
RU - Federazione Russa 34
FR - Francia 27
HK - Hong Kong 27
CA - Canada 26
IR - Iran 24
AU - Australia 17
TR - Turchia 17
AT - Austria 15
ID - Indonesia 12
PK - Pakistan 11
SA - Arabia Saudita 11
IL - Israele 10
ES - Italia 9
BR - Brasile 8
ET - Etiopia 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
KR - Corea 6
BY - Bielorussia 5
DZ - Algeria 5
RO - Romania 5
UA - Ucraina 5
AR - Argentina 4
EG - Egitto 4
NO - Norvegia 4
PH - Filippine 4
BE - Belgio 3
MX - Messico 3
PL - Polonia 3
BG - Bulgaria 2
CH - Svizzera 2
EU - Europa 2
MA - Marocco 2
MK - Macedonia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
IQ - Iraq 1
KZ - Kazakistan 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
Totale 8.042
Città #
Lawrence 812
Princeton 811
Ashburn 463
New York 335
Milan 274
Shanghai 187
Dublin 119
Helsinki 113
Washington 82
Rome 77
Castelseprio 61
Pune 59
Los Angeles 50
Seattle 49
Chandler 29
Dronten 23
Hong Kong 21
Bologna 20
Hanover 17
Borås 13
London 13
Genoa 12
Singapore 12
Brescia 10
Meppel 10
Turin 10
Florence 9
Tokyo 9
Aksum 8
Boardman 8
Cambridge 8
Hyderabad 8
Lappeenranta 8
Shijiazhuang 8
Verona 8
Ancona 7
Bangkok 7
Chicago 7
Elmendorf 7
Gatchina 7
Jakarta 7
Lahore 7
Paris 7
Philadelphia 7
Redwood City 7
San Jose 7
St Petersburg 7
Toronto 7
Andover 6
Ankara 6
Beijing 6
Bergamo 6
Falls Church 6
Livorno 6
Mountain View 6
Naples 6
Rockville 6
Santa Clara 6
Segrate 6
Vienna 6
Council Bluffs 5
Dalmine 5
Minsk 5
New Haven 5
Osimo 5
Overland Park 5
Palermo 5
Perth 5
Sharjah 5
Trieste 5
Vittoria 5
Al Qatif 4
Birmingham 4
Boston 4
Chaoyang 4
Chennai 4
Chevy Chase 4
Delhi 4
Elsternwick 4
Izmir 4
Kunming 4
Manchester 4
Michaelnbach 4
Montreal 4
Moscow 4
Osio Sotto 4
Palo Alto 4
Perugia 4
Quezon City 4
Rovereto 4
Senigallia 4
Siena 4
Tehran 4
Trondheim 4
Vicopisano 4
Winnipeg 4
Acate 3
Aci Sant'Antonio 3
Algiers 3
Angera 3
Totale 4.086
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 170
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 99
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 58
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 57
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 54
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 51
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 50
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 43
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 41
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 35
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 34
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 34
null 34
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 33
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 32
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 31
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 31
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 30
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 30
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 28
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 27
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 27
Integrated clinical role of echocardiography in patients with COVID-19 27
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 27
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 27
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 26
After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy 26
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 26
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 26
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 26
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT 25
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
Treosulfan-fludarabine-ATG-F based reduced-toxicity conditioning regimen: multicentre "Allo-Treo" study, results in 183 patients with haematological malignancies 25
Biobanking for COVID-19 research 25
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 25
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 25
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 25
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 24
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 24
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 24
MicroCLOTS pathophysiology in COVID 19 24
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 24
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 24
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 23
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 23
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 23
null 23
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 23
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 23
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 22
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 22
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 22
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 22
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 22
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 22
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis 22
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 22
COVID-19 mortality rate in nine high-income metropolitan regions 22
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 22
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 22
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 22
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 22
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 22
Testosterone in males with COVID-19: A twelve-month cohort study 21
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 21
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 21
FAS-based suicide gene strategy for controlled GvHD: An alternative to HSV-tk. 21
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 21
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 21
One-year mental health outcomes in a cohort of COVID-19 survivors 21
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial 21
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 21
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 21
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 20
Abrogation of GvHD and early immune reconstitution after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. 20
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 20
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 20
RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study 20
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 20
Severely low testosterone in males with COVID-19: a case-control study 20
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 20
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 20
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 20
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 19
Raman spectroscopy for the assessment of acute myeloid leukemia: A proof of concept study 19
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 19
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 19
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 19
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 19
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 19
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 19
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 19
Subclinical myocardial dysfunction in patients recovered from COVID-19 19
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 19
Breakthrough invasive fungal infections in allogeneic hematopoietic stem cell transplantation 19
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 19
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 18
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 18
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 18
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 18
Totale 2.734
Categoria #
all - tutte 146.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020111 87 2 1 3 0 0 1 0 1 2 10 4
2020/2021234 6 5 17 68 16 51 20 8 25 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20242.773 201 226 396 356 327 626 192 273 29 137 10 0
Totale 8.978